The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A three-dimensional human neural cell culture model of Alzheimer’s disease
Open accessAbstract
Alzheimer's disease is the most common form of dementia, characterized by two pathological hallmarks: amyloid-β plaques and neurofibrillary tangles. The amyloid hypothesis of Alzheimer's disease posits that the excessive accumulation of amyloid-β peptide leads to neurofibrillary tangles composed of aggregated hyperphosphorylated tau. However, to date, no single disease model has serially linked these two pathological events using human neuronal cells. Mouse models with familial Alzheimer's disease (FAD) mutations exhibit amyloid-β-induced synaptic and memory deficits but they do not fully recapitulate other key pathological events of Alzheimer's disease, including distinct neurofibrillary tangle pathology. Human neurons derived from Alzheimer's disease patients have shown elevated levels of toxic amyloid-β species and phosphorylated tau but did not demonstrate amyloid-β plaques or neurofibrillary tangles. Here we report that FAD mutations in β-amyloid precursor protein and presenilin 1 are able to induce robust extracellular deposition of amyloid-β, including amyloid-β plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system. More importantly, the 3D-differentiated neuronal cells expressing FAD mutations exhibited high levels of detergent-resistant, silver-positive aggregates of phosphorylated tau in the soma and neurites, as well as filamentous tau, as detected by immunoelectron microscopy. Inhibition of amyloid-β generation with β- or γ-secretase inhibitors not only decreased amyloid-β pathology, but also attenuated tauopathy. We also found that glycogen synthase kinase 3 (GSK3) regulated amyloid-β-mediated tau phosphorylation. We have successfully recapitulated amyloid-β and tau pathology in a single 3D human neural cell culture system. Our unique strategy for recapitulating Alzheimer's disease pathology in a 3D neural cell culture model should also serve to facilitate the development of more precise human neural cell models of other neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Beading or blebbing in neurites is a marker of dystrophic neurites in the AD brain (3, 42, 43).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In AD, tau protein becomes hyperphosphorylated, resulting in tau dissociating from microtubules and forming insoluble tau aggregates in the neurites and cell bodies (3, 37).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In iPSC-derived neurons from both FAD- and SAD-patients, pTau aberrantly accumulates at early time points (Choi et al., 2014, Israel et al., 2012, Moore et al., 2015, Muratore et al., 2014, Ochalek et al., 2017, Shi et al., 2012).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Choi et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Modeling these pathological hallmarks has largely relied on transgenic cellular and animal models harboring genetic mutations linked to ADAD (3–5).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“As for human neurons, previous studies focused on overexpressing mutant APP and Presenilin in REN stem cells grown in a 3D culture (3), which differs from patient-specific LOAD model that relies on the endogenous recapitulation of AD-associated phenotypes as provided in this study.”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
In the citing paper
“one study revealed that familial AD (FAD) mutations in β-amyloid precursor protein and presenilin 1 induced robust extracellular deposition of amyloid-β in a human neural stem-cell-derived 3D culture system85.”
From The use of brain organoids to investigate neural development and disease (2017) · cites this paper as [85]
In the citing paper
“the 3D-differentiated neuronal cells expressing FAD mutations exhibited aggregates of phosphorylated tau as well as filamentous tau.”
From The use of brain organoids to investigate neural development and disease (2017) · cites this paper as [85]
In the citing paper
“A 3D in vitro culture system consisting of human neurons differentiated from induced pluripotent stem cells overexpressing human APP containing FAD mutations generates robust Aβ42 production and amyloid deposition. Importantly, this model also develops elevated phospho-tau levels and fibrillary tau aggregates, suggesting that elevated Aβ levels alone are sufficient to drive tau pathology in human”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Choi et al., 2014
In the citing paper
“It was recently shown that development of a 3D culture of human neural stem cells transfected with APPK670N/M671L/V717I and PS1ΔE9 in Matrigel scaffolding resulted in the extracellular aggregation of Aβ into plaques and the intracellular aggregation of tau in dystrophic neurites and the cell soma [23, 77].”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Self-citationProbing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,211
Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741
Modeling familial Alzheimer's disease with induced pluripotent stem cells
Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., Yamanaka, S., Okano, H., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr394 · Cited by 599
Cohen, R. M., Rezai-Zadeh, K. P., Weitz, T. M., Rentsendorj, A., Gate, D., Spivak, I. E., Bholat, Y., Vasilevko, V., Glabe, C. G., Breunig, J. J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3672-12.2013 · Cited by 555
Muratore, C. R., Rice, H. C., Srikanth, P., Callahan, D. G., Shin, T., Benjamin, L. N. P., Walsh, D. M., Selkoe, D. J., & Young-Pearse, T. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu064 · Cited by 379
Flagged first, then by citations
Research works printed but not linked: 1
- Higuchi, M., Trojanowski, J. Q. & Lee, V. M.-Y. Tau protein and tauopathy. Neuropsychopharmacology: The Fifth Generation of Progress (eds Davis, K. L., Charney, D., Coyle, J. T. & Nemeroff, C. ) 1339–1354 (Lippincott, Williams & Wilkins, 2002)
Cited by
Sorted by citations
Items 801–900 of 998
Remote Associations Between Tau and Cortical Amyloid-β Are Stage-Dependent
Hojjati, S. H., Chiang, G. C.-Y., Butler, T., de Leon, M. J., Gupta, A. K., Li, Y., Sabuncu, M. R., Feiz, F., Nayak, S., Shteingart, J., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231362 · Cited by 9
Deng, J., Liu, B., Tao, Q., Luo, Y., Zhu, Y., Huang, X., & Yue, F. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.04.002 · Cited by 8
Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective
Calvo, B., Schembri-Wismayer, P., & Alonso, M. B. D. (2025) · Cells · doi:10.3390/cells14050347 · Cited by 9
Utilization of stem cells to model Parkinson's disease – current state and future challenges
Hillje, A., & Schwamborn, J. C. (2016) · Future Neurology · doi:10.2217/fnl.16.7 · Cited by 7
Harris, A. R., McGivern, P., & Ooi, L. (2019) · The Neuroscientist · doi:10.1177/1073858419870446 · Cited by 8
Obal, D., & Wu, J. C. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15228 · Cited by 8
Maigler, K. C., Buhr, T. J., Park, C. S., Miller, S. A., Kozlowski, D. A., & Marr, R. A. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.6989 · Cited by 8
Screening neuroprotective compounds in herpes-induced Alzheimer's disease cell and 3D tissue models
Silveira, I. A., Mullis, A. S., Cairns, D. M., Shevzov-Zebrun, A., Whalen, J., Galuppo, A., Walsh, K. G., & Kaplan, D. L. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.05.002 · Cited by 9
Phadke, L., Lau, D. H. W., Aghaizu, N. D., Ibarra, S., Navarrón, C. M., Granat, L., Magno, L., Whiting, P. J., & Jolly, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1056067 · Cited by 8
Kostadinova, I., Kondeva-Burdina, M., Marinov, L., Vezenkov, L., & Simeonova, R. (2023) · Life · doi:10.3390/life13010139 · Cited by 8
Seely, E. W., & Grinspoon, S. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802101-9.00002-8 · Cited by 9
The puzzle of preserved cognition in the oldest old
Bugiani, O. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04111-y · Cited by 8
Zhang, Y., Fu, T., Han, S., Ding, Y., Wang, J., Zheng, J., & Li, J. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.4.44 · Cited by 8
Frühauf, M., Zeitschel, U., Höfling, C., Ullm, F., Rabiger, F. V., Alber, G., Pompe, W., Müller, U., & Roßner, S. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14978 · Cited by 8
Massachusetts Alzheimer's Disease Research Center: Progress and challenges
Hyman, B. T., Growdon, J. H., Albers, M. W., Buckner, R. L., Chhatwal, J. P., Gómez‐Isla, T., Haass, C., Hudry, E., Jack, C. R., Johnson, K. A., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.1887 · Cited by 8
Self-citationRole for cell death pathway in Alzheimer’s disease
Sirkis, D. W., & Yokoyama, J. S. (2023) · Science · doi:10.1126/science.adk2009 · Cited by 8
Rao, A. T., Chen, N., Kim, M. J., Blumenfeld, J. R., Yip, O., Hao, Y., Liang, Z., Nelson, M. R., Koutsodendris, N., Grone, B. P., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.10.566510 · Cited by 8
Kuhn, M. K., Kang, R. Y., Kim, C., Tagay, Y., Morris, N., Tabdanov, E. D., Elcheva, I. A., & Proctor, E. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.16.567220 · Cited by 9
Mapping amyloid beta predictors of entorhinal tau in preclinical Alzheimer's disease
Zamani, J., Vahid, A., Avelar‐Pereira, B., Gozdas, E., Hosseini, S. M. H., & Initiative, A. D. N. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14499 · Cited by 9
Wang, W., Tan, S., Zuo, X., Gao, X., Ma, L., Sun, R., Liang, G., Yin, L., Pu, Y., & Zhang, J. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05293-7 · Cited by 7
Intracellular tracing of amyloid vaccines through direct fluorescent labelling
Mold, M. J., Kumar, M., Mirza, A., Shardlow, E., & Exley, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-20845-9 · Cited by 7
Robust Tissue Fabrication for Long-Term Culture of iPSC-Derived Brain Organoids for Aging Research
Koch, L. S., Buentello, D. C., & Broersen, K. (2023) · Journal of Visualized Experiments · doi:10.3791/64586 · Cited by 8
Han, S., Kim, J., Kim, S. H., Youn, W., Kim, J., Ji, G. Y., Yang, S., Park, J., Lee, G. M., Kim, Y., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.09.046 · Cited by 7
Self-citationVila-Real, H. J., Coelho, H., Rocha, J. P., Fernandes, A. M. A., Ventura, M. R., Maycock, C. D., Iranzo, O., & Simplı́cio, A. L. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00658 · Cited by 7
Deriving, regenerating, and engineering CNS tissues using human pluripotent stem cells
Lemke, K. A., Aghayee, A., & Ashton, R. S. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.05.010 · Cited by 8
Egawa, N., Suzuki, H., Takahashi, R., Hayakawa, K., Li, W., Lo, E. H., Arai, K., & Inoue, H. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20910324 · Cited by 8
Maltsev, A. V., Nikiforova, A. B., Bal, N. V., & Balaban, P. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911848 · Cited by 7
Daoutsali, E., Pepers, B. A., Stamatakis, S., van der Graaf, L. M., Terwindt, G. M., Parfitt, D. A., Buijsen, R. A. M., & van Roon‐Mom, W. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1048584 · Cited by 8
Emerging concepts towards a translational framework in Alzheimer’s disease
Cozachenco, D., Zimmer, E. R., & Lourenco, M. V. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105246 · Cited by 7
Neurotherapies and Alzheimer: a protocol oriented review.
Vigil, J., & Tataryn, L. (2017) · NeuroRegulation · doi:10.15540/nr.4.2.79 · Cited by 7
Julian, D. L., Hollingsworth, E. W., Julian, K. A., & Imitola, J. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.07.002 · Cited by 7
Mulder, C. K., Dong, Y., Brugghe, H. F., Timmermans, H., Tilstra, W., Westdijk, J., van Riet, E., STEEG, H. V., Hoogerhout, P., & Eisel, U. L. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151136 · Cited by 7
Hogstrom, L. J., Guo, S.-M., Murugadoss, K., & Bathe, M. (2015) · Interface Focus · doi:10.1098/rsfs.2015.0081 · Cited by 7
Human iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Three-dimensional cell culture technologies in the study of Alzheimer’s disease: a narrative review
Chacón, P. E. A., Irineo‐Moreno, V., & Loera‐Valencia, R. (2025) · Advanced technology in neuroscience . · doi:10.4103/atn.atn-d-24-00016 · Cited by 6
Three-dimensional human brain organoids: A next-generation model to decode Alzheimer’s disease
Kumari, S., Ashvin, Dhapola, R., Sharma, P., Paidlewar, M., Vellingiri, B., Medhi, B., & HariKrishnaReddy, D. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102928 · Cited by 6
The Function, Underlying Mechanism and Clinical Potential of Exosomes in Colorectal Cancer
Jinhong, H., Ma, S., Zhao, Y., Wang, B., Ding, S., & Hu, Y. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2811302 · Cited by 6
Pereira, M. F., Shyti, R., & Testa, G. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.05.004 · Cited by 8
Hou, B.-Y., Wu, M.-H., Hsu, H.-Y., Lin, Y., & Yang, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137316 · Cited by 6
Geometrically engineered organoid units and their assembly for pre-construction of organ structures
Kadotani, A., Hayase, G., & Yoshino, D. (2024) · APL Bioengineering · doi:10.1063/5.0222866 · Cited by 7
Akkouh, I. A., Osete, J. R., Szabó, A., Andreassen, O. A., & Djurovic, S. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.02.012 · Cited by 9
Bilginer-Kartal, R., & Yıldız, A. A. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202400658 · Cited by 6
3D In Vitro Neuron on a Chip for Probing Calcium Mechanostimulation
Bobo, J., Garg, A., Venkatraman, P., Puthenveedu, M. A., & LeDuc, P. R. (2020) · Advanced Biosystems · doi:10.1002/adbi.202000080 · Cited by 6
Gazarian, K. G., Ramírez-García, L. R., Orozco, L. T., Luna‐Muñoz, J., & Pacheco‐Herrero, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.612657 · Cited by 6
Volloch, V., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.-v2-id1010 · Cited by 6
Structural biology of cell surface receptors implicated in Alzheimer’s disease
Hermans, S. J., Nero, T. L., Morton, C. J., Gooi, J. H., Crespi, G. A. N., Hancock, N. C., Gao, C., Ishii, K., Markulić, J., & Parker, M. W. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00903-9 · Cited by 6
Transcription-associated DNA DSBs activate p53 during hiPSC-based neurogenesis
Michel, N., Raimer, H. M., Atkin, N. D., Arshad, U., Al-Humadi, R. N., Singh, S., Manukyan, A., Gore, L. N., Burbulis, I. E., Wang, Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16516-5 · Cited by 6
Inflammation-Mediated Responses in the Development of Neurodegenerative Diseases
Nainu, F., Mamada, S. S., Harapan, H., & Emran, T. B. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_3 · Cited by 6
Bioengineered cell culture systems of central nervous system injury and disease
Teixeira, F. G., Vasconcelos, N. L., Gomes, E. D., Marques, F., Sousa, J. C., Sousa, N., Silva, N. A., Assunção-Silva, R. C., Lima, R., & Salgado, A. J. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.04.020 · Cited by 6
Salem, H., Rocha, N. P., Colpo, G. D., & Teixeira, A. L. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160250 · Cited by 6
Modeling neurodegenerative disorders in adult somatic cells: A critical review
Truong, A. N., Si, E., Duncan, T., & Valenzuela, M. (2016) · Frontiers in Biology · doi:10.1007/s11515-016-1413-3 · Cited by 6
The Genetic Basis of Alzheimer’s Disease
Hooli, B. V., & Tanzi, R. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00002-2 · Cited by 6
Self-citationJoffe, A. R., Bara, M., Anton, N. R., & Nobis, N. (2016) · Alternatives to Laboratory Animals · doi:10.1177/026119291604400407 · Cited by 6
Choi, J. Y., Park, M., Cho, H., Kim, M., Kang, K., & Choi, I. S. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00300 · Cited by 6
LRP::FLAG Reduces Phosphorylated Tau Levels in Alzheimer’s Disease Cell Culture Models
Cuttler, K., Bignoux, M. J., Otgaar, T. C., Chigumba, S., Ferreira, E., & Weiss, S. F. T. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200244 · Cited by 6
Bio-Inspired Hydrogels via 3D Bioprinting
Nie, L., Wang, C., Deng, Y., & Shavandi, A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.94985 · Cited by 6
A Comprehensive Update of Cerebral Organoids between Applications and Challenges
Li, X., Shopit, A., & Wang, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7264649 · Cited by 6
Development of surface functionalization strategies for 3D‐printed polystyrene constructs
Lerman, M. J., Muramoto, S., Arumugasaamy, N., Order, M. V., Lembong, J., Gerald, A. G., Gillen, G. J., & Fisher, J. P. (2019) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.34347 · Cited by 6
Li, L., Roh, J. H., Kim, H. J., Park, H. J., Kim, M., Koh, W., Heo, H., Chang, J. W., Nakanishi, M., Yoon, T., et al. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.3.329 · Cited by 6
The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6
Shojaei, S., Basso, J., Amereh, M., Alizadeh, J., Dehesh, T., Rosa, S. C. D. S., Clark, C. J., Hassan, M., Tomczyk, M., Cole, L., et al. (2022) · Research Square · doi:10.1101/2022.10.29.514383 · Cited by 7
Buchholz, S., Bell, M. J., Kabbani, M. A. A., Kluge, L., Cagkmak, C., Klimek, J., & Zempel, H. (2022) · Research Square · doi:10.21203/rs.3.rs-2277268/v1 · Cited by 6
TYK2 as a novel therapeutic target in Alzheimer’s Disease with TDP-43 inclusionsPreprint
König, L. E., Rodriguez, S., Hug, C. B., Daneshvari, S., Chung, A., Bradshaw, G. A., Şahin, A., Zhou, G., Eisert, R. J., Piccioni, F., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.04.595773 · Cited by 6
Far, B. F., Omidvar, K., Heidari, E., Ebrahimi, M., Mohammadi, Y., & Ertaş, Y. N. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00407 · Cited by 5
Dannert, A., Schulz, N., Klimmt, J., Knez, L., Groschup, B., Gonçalves, C. C., Carraro, C., Schifferer, M., Brendel, M., & Paquet, D. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adu9845 · Cited by 6
Vascular Heparan Sulfate and Amyloid-β in Alzheimer’s Disease Patients
McMillan, I. O., Gearing, M., & Wang, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073964 · Cited by 7
Carr, L. M., Mustafa, S., Care, A., & Collins‐Praino, L. E. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.023 · Cited by 5
Volloch, V., & Rits‐Volloch, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116036 · Cited by 6
Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States
Kuhn, M. K., & Proctor, E. A. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26723 · Cited by 5
Kumar, D. K. V., Mitchell, T., Tailor, B. A., Moir, A. P., Shanmugam, N. K. N., Eimer, W. A., Ghelichi, J., Choi, S. H., Su, C., Rodriguez, A. S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70490 · Cited by 8
Self-citationStem cell-based therapeutic strategies for down syndrome and Alzheimer’s disease
Hamadelseed, O., & Skutella, T. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04556-3 · Cited by 5
Øhlenschlæger, M. S., Jensen, P., Havelund, J. F., Schmidt, S. I., Mohamed, F. A., Sutcliffe, M. A., Elmkvist, S. B., Criscuolo, L., Wingett, S., Chiaradia, I., et al. (2026) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.101295 · Cited by 5
Linking CSF and cognition in Alzheimer's disease: Reanalysis of clinical data
Guhra, M., Thomas, C., Boedeker, S., Kreisel, S. H., Drießen, M., Beblo, T., Ohrmann, P., & Toepper, M. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.11.008 · Cited by 5
Suenaga, H., Kagaya, N., Kawada, M., Tatsuda, D., Sato, T., & Shin‐ya, K. (2021) · The Journal of Antibiotics · doi:10.1038/s41429-021-00457-8 · Cited by 5
The role of Aβ in Alzheimer's Disease as an Evolutionary Outcome of Optimized Innate Immune Defense
Tatar, M. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.68 · Cited by 6
Human Brain Banking as a Convergence Platform of Neuroscience and Neuropsychiatric Research
Liu, F., Yin, X., Cong, C., Wang, Y., & Ma, C. (2022) · Human Brain · doi:10.37819/hb.001.001.0204 · Cited by 5
Hernaiz, A., Cobeta, P., Marín, B., Vázquez, F. J., Badiola, J. J., Zaragoza, P., Bolea, R., & Martín‐Burriel, I. (2023) · Animals · doi:10.3390/ani13061043 · Cited by 5
Thin-film conformal fluorescent SU8-phenylenediamine
Barhum, H., Kolchanov, D. S., Attrash, M., Unis, R., Alnis, J., Salgals, T., Yehia, I., & Ginzburg, P. (2023) · Nanoscale · doi:10.1039/d3nr02744a · Cited by 5
Leveraging Biomaterial Platforms to Study Aging-Related Neural and Muscular Degeneration
Hidalgo‐Alvarez, V., & Madl, C. M. (2024) · Biomolecules · doi:10.3390/biom14010069 · Cited by 5
Cui, M., Wu, W., Li, Q., Qi, G., Liu, X., Bai, J., Chen, M., Li, P., & Sun, X. S. (2024) · Cells · doi:10.3390/cells13020143 · Cited by 6
Dhaliwal, A. (2015) · Cited by 5
Carter, S. D., Liu, X., Yue, Z., & Wallace, G. G. (2017) · MRS Communications · doi:10.1557/mrc.2017.96 · Cited by 5
Cellular response to synthetic polymers
Baican, M. C., Stoleru, E., & Vasile, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102967-1.00014-1 · Cited by 5
Mahairaki, V., Kim, S. Y., & Li, J. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303019 · Cited by 5
Ultrasound shear-wave computed tomography for elasticity imaging
Jeng, G.-S., Yeh, C.-L., Lee, C., Yang, Y.-S., Tseng, L.-Y., & Li, P. (2022) · Applied Physics Letters · doi:10.1063/5.0100628 · Cited by 5
Salgado, B., Sastre, I., Bullido, M. J., & Aldudo, J. (2023) · Microorganisms · doi:10.3390/microorganisms11051205 · Cited by 6
Soares, E. S., Kim, B.-H., Reser, L., Chow, R. L., Delaney, K. R., Esteller, M., Ross, M. M., Shabanowitz, J., Hunt, D. F., Guil, S., et al. (2023) · Epigenetics · doi:10.1080/15592294.2023.2276425 · Cited by 5
Harasta, A. E., & Ittner, L. M. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_1 · Cited by 5
Rodriguez, S., Schrank, B. R., Şahin, A., Lawati, H. J. A., Costantino, I. M., Benz, E. G., Fard, D., Albers, A. D., Cao, L., Gomez, A. C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/248328 · Cited by 5
Sullivan, M. A., Lane, S. D., Volkerling, A. M., Engel, M., Werry, E. L., & Kassiou, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.22541/au.166852614.45511209/v1 · Cited by 5
In vitro engineered models of neurodegenerative diseases
Morçimen, Z. G., Taşdemir, Ş., & Şendemir, A. (2024) · Biocell · doi:10.32604/biocell.2023.045361 · Cited by 4
Jalali, H., Rahimian, S., Shahsavarian, N., Norouzi, R., Ahmadiyeh, Z., Najafi, H., & Golchin, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123198 · Cited by 4
Advancements in brain organoid models for neurodegenerative disease research
Park, S., & Park, J. (2024) · Organoid · doi:10.51335/organoid.2024.4.e12 · Cited by 4
Prasannan, P., Siney, E. J., Chatterjee, S., Johnston, D. A., Shah, M., Mudher, A. K., & Willaime‐Morawek, S. (2022) · In vitro models · doi:10.1007/s44164-022-00038-5 · Cited by 4
Bibliometric analysis of cerebral organoids and diseases in the last 10 years
Luo, B., Liu, K., & Fan, J. (2023) · Ibrain · doi:10.1002/ibra.12139 · Cited by 5
Research Progress on Neural Cell Culture Systems
Li, T., Qin, X., & Ao, Q. (2025) · Current Neuropharmacology · doi:10.2174/011570159x360193250219082312 · Cited by 4
Real-time monitoring of amyloid growth in a rigid gel matrix
Dalpadado, R. C., Maat, H., Carver, J. A., & Hall, D. R. (2016) · Analytical Biochemistry · doi:10.1016/j.ab.2016.07.024 · Cited by 4
Application and prospects of high-throughput screening for in vitro neurogenesis
Zhang, S., Zhao, J., Ni, J.-J., Li, H., Quan, Z., & Qing, H. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i6.393 · Cited by 4
Slota, J. A., Wang, X., Lusansky, D., Medina, S. J., & Booth, S. A. (2023) · Prion · doi:10.1080/19336896.2023.2206315 · Cited by 4
Zellmer, J. C., Lomoio, S., Tanzi, R. E., & Bhattacharyya, R. (2025) · Journal of Visualized Experiments · doi:10.3791/66129 · Cited by 4
Self-citation
Metadata
- Authors
- Choi, S. H., Kim, Y. H., Hebisch, M., Sliwinski, C., Lee, S., D’Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., Klee, J. B., Zhang, C., Wainger, B. J., Peitz, M., Kovacs, D. M., Woolf, C. J., Wagner, S. L., Tanzi, R. E., & Kim, D. Y.
- Affiliations
- Harvard University (US)
- University of Bonn (DE)
- Boston Children's Hospital (US)
- Whitehead Institute for Biomedical Research (US)
- University of California San Diego (US)
- Corresponding author
- Tanzi, Rudolph E.
- Kim, Doo Yeon
- ORCID
- Venue
- Nature
- Published
- 2014-10-12
- Volume
- 515
- Issue
- 7526
- Pages
- 274-278
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4366007
- OpenAlex
- W2126231259
- Cited by
- 1,195
- References
- 30
- Citations by year
- 2026: 67 · 2025: 75 · 2024: 95 · 2023: 88 · 2022: 112 · 2021: 111 · 2020: 141 · 2019: 109 · 2018: 109 · 2017: 87 · 2016: 97 · 2015: 87 · 2014: 14
- FWCI
- 63.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Massachusetts General Hospital
- Cure Alzheimer's Fund
- University of Edinburgh
- National Institute on Aging (5P01 AG15379, P01AG015379, R21AG031483, RF1AG048080, P50AG005134, R01AG014713, P01AG004953, P30AG062421)
- National Institute of Mental Health (R37MH060009)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, P30DK043351)
- National Institute of Neurological Disorders and Stroke (P30NS045776, R01NS045860)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD018655)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, familial Alzheimer's disease, amyloid plaques, tauopathy, neurofibrillary tangles, amyloid hypothesis, presenilin 1 mutations, human neural stem cells, 3D cell culture, human neurons, beta-secretase inhibition, gamma-secretase inhibition, tau phosphorylation, drug screening model
- MeSH terms
- Alzheimer Disease, Cell Differentiation, Drug Evaluation, Preclinical, Extracellular Space, Humans, Microtubule-Associated Proteins, Models, Biological, Phosphorylation, Reproducibility of Results, Amyloid beta-Peptides, Neurites, tau Proteins, Cell Culture Techniques, Glycogen Synthase Kinase 3, Presenilin-1, Neural Stem Cells, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
